Amiodarone and the thyroid.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
S B Seminara, G H Daniels

Abstract

To review the amiodarone-associated alterations in thyroid hormone metabolism and thyroid function and compare them with the effects of inorganic iodide. To clarify the pathophysiologic features and treatment of amiodarone-associated hypothyroidism and thyrotoxicosis. Amiodarone, an iodinated benzofuran, is an important antianginal and antiarrhythmic medication. It also alters thyroid hormone metabolism and may precipitate hypothyroidism or hyperthyroidism. Amiodarone-associated hypothyroidism (AAH) is similar to iodine-induced hypothyroidism. Amiodarone-associated thyrotoxicosis (AAT) has a complex pathophysiology. Type I AAT is due to increased thyroid hormone synthesis and release and occurs in patients with multinodular goiter or Graves' disease. Therapeutic interventions may include discontinuation of amiodarone, thionamide therapy, perchlorate, or surgery. In type II AAT, hyperthyroidism is the consequence of a destructive thyroiditis with release of preformed thyroid hormone. Prednisone therapy is the treatment of choice. The distinction between these two entities is of considerable clinical and therapeutic importance.

References

Jan 5, 1979·Journal of Neurology·C MeierH P Ludin
Oct 1, 1979·The Journal of Clinical Endocrinology and Metabolism·L J DeGroot, P A Rue
Dec 1, 1976·The American Journal of Cardiology·M B RosenbaumM V Elizari
Feb 1, 1977·The Journal of Clinical Endocrinology and Metabolism·W JubizL D Lagerquist
Oct 1, 1975·The Journal of Clinical Endocrinology and Metabolism·J C SavoieF Leger
Jan 15, 1976·Biochemical Pharmacology·P Polster, J Broekhuysen
Jun 1, 1990·The Journal of Clinical Endocrinology and Metabolism·E RotiL E Braverman
Dec 1, 1990·European Journal of Clinical Investigation·O H ClarkS H Ingbar
Aug 1, 1990·Clinical Endocrinology·R RajatanavinT Himathongkam
Mar 16, 1990·JAMA : the Journal of the American Medical Association·A P FarwellL E Braverman
Dec 15, 1989·Biochemical Pharmacology·S A BeddowsS S Nussey
May 1, 1989·Progress in Cardiovascular Diseases·K NademaneeJ M Hershman
Aug 1, 1989·Acta Endocrinologica·V ForestiM Bianco
Jan 1, 1987·Hormone Research·E MartinoA Pinchera
Jan 1, 1989·The Journal of Clinical Investigation·M F Norman, T N Lavin
Aug 1, 1986·The Journal of Clinical Endocrinology and Metabolism·W M WiersingaE A van Royen
Nov 1, 1986·The Journal of Clinical Endocrinology and Metabolism·E MartinoM Safran
Jan 25, 1986·British Medical Journal·E MonteiroC Ribeiro
Jul 1, 1988·Acta Endocrinologica·M LambertC Beckers
Aug 13, 1988·BMJ : British Medical Journal·M SafranL E Braverman
Mar 1, 1988·Clinical Endocrinology·D F GardnerR D Utiger
Dec 1, 1988·Metabolism: Clinical and Experimental·E M KapteinA G Burger
Oct 1, 1988·Journal of the American Geriatrics Society·P J Drinka, W E Nolten
Jul 2, 1988·BMJ : British Medical Journal·A P WeetmanW McKenna
Dec 1, 1987·Journal of Endocrinological Investigation·S BalzanoE Martino
Jan 1, 1987·Acta Medica Scandinavica·B GudbjörnssonA B Hreidarsson
Jan 1, 1987·European Journal of Clinical Pharmacology·O Van ReethJ Unger
Feb 1, 1987·Clinical Endocrinology·E MartinoA Pinchera
Feb 1, 1986·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·A E PekaryY S Wang
Sep 1, 1986·The American Journal of the Medical Sciences·M SafranL E Braverman
Mar 1, 1987·The American Journal of Surgical Pathology·T C SmyrkJ A Carney
Jan 1, 1986·The American Journal of Cardiology·N Z KerinM Rubenfire
Mar 1, 1986·The Journal of Clinical Endocrinology and Metabolism·R H RaoG S Spathis
Mar 1, 1986·Annals of Internal Medicine·B RigasC A Riely
Mar 1, 1985·Annals of Internal Medicine·L E AlvesT B Cahill
Mar 1, 1985·The American Journal of Cardiology·R MeeseP Nicod
Mar 1, 1985·The American Journal of Medicine·G D BorowskiL N Horowitz
Mar 1, 1985·Clinical Endocrinology·J A FranklynM C Sheppard
Mar 1, 1985·Journal of the American Academy of Dermatology·A AlinoviM Gabrielli

❮ Previous
Next ❯

Citations

Aug 12, 2005·Current Surgery·C BirkedalR K Spence
Dec 20, 2002·General Hospital Psychiatry·Shusuke NumataTetsuro Ohmori
Apr 8, 2004·Thyroid : Official Journal of the American Thyroid Association·Laura E RyanRichard T Kloos
May 28, 2004·Clinical Nuclear Medicine·Joel R Smith, Elizabeth Oates
Nov 15, 2007·Journal of Medical Case Reports·Vasilios PapaioannouIoannis Pneumatikos
Jul 5, 2008·Clinical Drug Investigation·Ibrahim Halil KurtBulent Mustafa Karademir
Jul 14, 2001·Radiographics : a Review Publication of the Radiological Society of North America, Inc·C M IntenzoA E dePapp
Jul 11, 2003·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Charles M IntenzoDavid M Capuzzi
Oct 27, 2001·Clinical Endocrinology·K K Miller, G H Daniels
May 5, 2010·The American Journal of Geriatric Pharmacotherapy·Kevin T Foley, Karen S Bugg
Jul 2, 2005·The American Journal of Medicine·Shehzad Basaria, David S Cooper
Jun 17, 2006·Therapeutic Drug Monitoring·Thien-Giang Bach-Huynh, Jacqueline Jonklaas

❮ Previous
Next ❯

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.